Jafar Karami

4.4k total citations · 1 hit paper
40 papers, 1.8k citations indexed

About

Jafar Karami is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Jafar Karami has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 16 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Jafar Karami's work include Immune Cell Function and Interaction (10 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Systemic Lupus Erythematosus Research (6 papers). Jafar Karami is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Systemic Lupus Erythematosus Research (6 papers). Jafar Karami collaborates with scholars based in Iran, United States and Poland. Jafar Karami's co-authors include Mahdi Mahmoudi, Ahmadreza Jamshidi, Khadijeh Barzaman, Mohammad Hossein Kazemi, Elahe Safari, Shima Moradi‐Kalbolandi, Leila Farahmand, Zeinab Zarei‐Behjani, Saeed Aslani and Saeed Aslani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Gene.

In The Last Decade

Jafar Karami

38 papers receiving 1.8k citations

Hit Papers

Breast cancer: Biology, biomarkers, and treatments 2020 2026 2022 2024 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jafar Karami Iran 17 789 441 417 414 407 40 1.8k
Ming Jin China 20 643 0.8× 452 1.0× 115 0.3× 201 0.5× 351 0.9× 79 1.5k
Alessandro Morotti Italy 25 1.2k 1.5× 419 1.0× 117 0.3× 303 0.7× 342 0.8× 88 2.1k
Ricard Garcia‐Carbonell United States 11 649 0.8× 205 0.5× 366 0.9× 316 0.8× 263 0.6× 12 1.3k
Hannes Neuwirt Austria 23 787 1.0× 548 1.2× 88 0.2× 313 0.8× 418 1.0× 62 1.8k
Rong Shao China 21 981 1.2× 730 1.7× 104 0.2× 206 0.5× 463 1.1× 58 2.3k
Masanobu Tsubaki Japan 31 1.2k 1.5× 848 1.9× 71 0.2× 194 0.5× 660 1.6× 93 2.2k
Shinya Ohashi Japan 24 1.0k 1.3× 650 1.5× 215 0.5× 245 0.6× 481 1.2× 72 2.3k
Jeffrey A. Borgia United States 22 760 1.0× 378 0.9× 124 0.3× 132 0.3× 339 0.8× 104 1.5k
Yi Shen United States 26 1.4k 1.8× 238 0.5× 110 0.3× 297 0.7× 858 2.1× 49 2.0k
Jukka Vakkila Finland 20 352 0.4× 507 1.1× 77 0.2× 673 1.6× 193 0.5× 38 1.5k

Countries citing papers authored by Jafar Karami

Since Specialization
Citations

This map shows the geographic impact of Jafar Karami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jafar Karami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jafar Karami more than expected).

Fields of papers citing papers by Jafar Karami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jafar Karami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jafar Karami. The network helps show where Jafar Karami may publish in the future.

Co-authorship network of co-authors of Jafar Karami

This figure shows the co-authorship network connecting the top 25 collaborators of Jafar Karami. A scholar is included among the top collaborators of Jafar Karami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jafar Karami. Jafar Karami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masoumi, Maryam, et al.. (2025). The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment. Biochemistry and Biophysics Reports. 43. 102148–102148.
2.
Mousavi, Mohammad Javad, et al.. (2024). Evaluation of hematological markers as prognostic tools in rheumatoid arthritis. BMC Rheumatology. 8(1). 75–75. 4 indexed citations
4.
Masoumi, Maryam, et al.. (2024). Unraveling the immunometabolism puzzle: Deciphering systemic sclerosis pathogenesis. Heliyon. 10(15). e35445–e35445. 4 indexed citations
5.
Karami, Jafar, Ali‐Akbar Delbandi, Mehdi Shekarabi, et al.. (2024). TAK-242 (Resatorvid) inhibits proinflammatory cytokine production through the inhibition of NF-κB signaling pathway in fibroblast-like synoviocytes in osteoarthritis patients. Advances in Rheumatology. 64(1). 46–46. 3 indexed citations
6.
Yousefi, Bahman, et al.. (2023). Immunomodulatory effects of probiotic supplementation in patients with asthma: a randomized, double-blind, placebo-controlled trial. Allergy Asthma and Clinical Immunology. 19(1). 1–1. 16 indexed citations
7.
Masoumi, Maryam, et al.. (2022). Role of T Cells in the Pathogenesis of Rheumatoid Arthritis: Focus on Immunometabolism Dysfunctions. Inflammation. 46(1). 88–102. 22 indexed citations
8.
Shirkoohi, Reza, et al.. (2022). Evaluation of CX3CR1 gene DNA methylation in developmental dysplasia of the hip (DDH). Journal of Orthopaedic Surgery and Research. 17(1). 436–436. 3 indexed citations
9.
Kazemi, Mohammad Hossein, Alireza Najafi, Jafar Karami, et al.. (2021). Immune and metabolic checkpoints blockade: Dual wielding against tumors. International Immunopharmacology. 94. 107461–107461. 14 indexed citations
10.
Mousavi, Mohammad Javad, Elham Farhadi, Mohammad Vodjgani, et al.. (2021). Role of Fibroblast Activation Protein Alpha in Fibroblast-like Synoviocytes of Rheumatoid Arthritis. SHILAP Revista de lepidopterología. 20(3). 338–349. 14 indexed citations
11.
Karami, Jafar, et al.. (2020). Role of autophagy in the pathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches. Life Sciences. 254. 117734–117734. 51 indexed citations
12.
Masoumi, Maryam, et al.. (2020). Correction to: Destructive Roles of Fibroblast-Like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis. Inflammation. 44(2). 480–480. 1 indexed citations
13.
Masoumi, Maryam, et al.. (2020). Destructive Roles of Fibroblast-like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis. Inflammation. 44(2). 466–479. 84 indexed citations
14.
Barzaman, Khadijeh, Jafar Karami, Zeinab Zarei‐Behjani, et al.. (2020). Breast cancer: Biology, biomarkers, and treatments. International Immunopharmacology. 84. 106535–106535. 566 indexed citations breakdown →
15.
Masoumi, Maryam, et al.. (2020). Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: Latest evidence and therapeutic approaches in rheumatoid arthritis. International Immunopharmacology. 89(Pt A). 107064–107064. 49 indexed citations
16.
Karami, Jafar, Saeed Aslani, Ahmadreza Jamshidi, Masoud Garshasbi, & Mahdi Mahmoudi. (2019). Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review. Gene. 702. 8–16. 143 indexed citations
17.
Aslani, Saeed, et al.. (2017). Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous. Inflammation Research. 66(12). 1057–1073. 22 indexed citations
18.
Mahmoudi, Mahdi, Ahmadreza Jamshidi, Jafar Karami, et al.. (2016). Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.. SHILAP Revista de lepidopterología. 15(1). 27–38. 16 indexed citations
19.
Aslani, Saeed, et al.. (2016). Epigenetic Modifications and Therapy in Multiple Sclerosis. NeuroMolecular Medicine. 19(1). 11–23. 52 indexed citations
20.
Alesaeidi, ‬‬Samira, Jafar Karami, Mahdi Mahmoudi, et al.. (2015). Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus. Inflammation. 38(6). 2185–2190. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026